The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre
Welcome,         Profile    Billing    Logout  
 11 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sievenpiper, John L
PortfolioEx, NCT02481466: The Combined Portfolio Diet and Exercise Study

Completed
N/A
232
Canada
Portfolio diet and structured exercise, Dietary Portfolio of cholesterol-lowering foods, Enhanced portfolio, Low Glycemic Index Portfolio, Portfolio Plus diet, Laval exercise program, structured exercise program, Portfolio diet, structured exercise, DASH-like diet and structured exercise, Modified DASH diet, high fibre diet, DASH-like diet, Portfolio diet and routine exercise, routine exercise, DASH-like diet and routine exercise
Unity Health Toronto, Canadian Institutes of Health Research (CIHR), University of Toronto, Laval University, University of Manitoba, University of British Columbia
Cardiovascular Diseases, Hypercholesterolemia, Type 2 Diabetes, Metabolic Syndrome
06/23
06/23
NCT04327713: Meta-analysis of Fish Oil Supplementation and Cardiovascular Outcomes in Diabetes

Active, not recruiting
N/A
1
Canada
fish oil supplement
University of Toronto, Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), Canadian Institutes of Health Research (CIHR), Diabetes Canada
Type2 Diabetes, Heart Failure, Myocardial Infarction, Stroke, Arrhythmia, Cardiovascular Diseases
03/21
04/21
NCT04633070: Systematic Review of Health App Gamification for Lifestyle Intervention Adherence

Active, not recruiting
N/A
100
Canada
Gamification
University of Toronto
Mobile Applications, Diet, Healthy, Behavior, Health
11/21
11/22
NCT04861545: Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction

Not yet recruiting
N/A
1
Canada
Soy, Isolated soy protein food sources, Non-Isolated soy protein food sources of soy protein
John Sievenpiper
Dyslipidemias, Cardiovascular Risk Factor, Dysglycemia
05/22
05/22
NCT05637866: SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes

Active, not recruiting
N/A
1
Canada
Soy milk
University of Toronto
Cardiovascular Diseases, Lipid Disorder, Metabolic Disease, Non-Alcoholic Fatty Liver Disease
03/23
10/23
DRI-DHA, NCT06294067: A Dose Response Investigation of Docosahexaenoic Acid (DHA)

Recruiting
N/A
72
Canada
docosahexaenoic acid (DHA), soybean oil placebo
University of Toronto, Unity Health Toronto
Nutrition, Healthy
04/25
09/25
NCT05191160: The Soy Treatment Evaluation for Metabolic Health (STEM) Trial

Active, not recruiting
N/A
186
Canada
Soy Milk, Cow's Milk, Sugar Sweetened Beverages
University of Toronto, United Soybean Board
Metabolic Syndrome, Overweight and Obesity, PreDiabetes, Diabetes, Healthy Obesity, Metabolically, Overweight, Obesity, Dysglycemia, Cardiovascular Diseases, Heart Disease Risk Factors, Hypertension, Dyslipidemias
10/24
03/25
NCT05171283: Meta-analysis of Oat Fiber and Cardiovascular Risk Reduction

Active, not recruiting
N/A
1
Canada
Oats or Oat Fibre
University of Toronto, Canadian Institutes of Health Research (CIHR), Quaker Oats Centre of Excellence, Quaker
Cardiovascular Diseases, Coronary Heart Disease
05/24
12/24
NCT05638061: SRMA of the Effect of Soy Protein on Blood Pressure

Active, not recruiting
N/A
1
Canada
Soy protein, Soya, soybean, soy bean, soya bean
University of Toronto
Blood Pressure, Cardiovascular Diseases
09/24
12/24
Ho, Thanh
ELU-FRα-1, NCT05001282: A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Terminated
1/2
79
US
ELU001, FA-CDC
Elucida Oncology
Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma, Endometrial Cancer, Ovary Cancer, Ovary Neoplasm, Ovary Disease, Ovary Metastasis, Ovarian Diseases, Ovarian Cancer Stage, Ovarian Epithelial Cancer, Ovarian Adenocarcinoma, Ovarian Serous Adenocarcinoma, Ovarian Neoplasm Epithelial, Ovarian Cancer Recurrent, Endometrial Diseases, Endometrial Adenocarcinoma, Endometrial Carcinosarcoma, Endometrial Clear Cell Adenocarcinoma, Endometrioid Adenocarcinoma, Endometrial Neoplasms, Endometrial Cancer Recurrent, Endometrioid Tumor, Fallopian Tube Cancer, Peritoneal Cancer
06/24
06/24
CFT8634-1101, NCT05355753: A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors

Terminated
1
49
US
CFT8634
C4 Therapeutics, Inc.
Synovial Sarcoma, Soft Tissue Sarcoma
12/23
12/23
NCT05115292: A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma

Active, not recruiting
1
85
US
BJ-005
BJ Bioscience, Inc.
Advanced Solid Tumor or Lymphoma
10/24
10/25
Khayyat, Rana
No trials found
Khan, Kashif
No trials found
Mazhar, Nourah
No trials found

Download Options